Glucose is a key metabolic regulator of osteoclasts; glucose stimulated increases in ATP/ADP ratio and calmodulin kinase II activity

Biochemistry and Cell Biology

Volumn 83, Issue 5, 2005, Pages 667-673

  Larsen, Kirsten I ^a   Falany, Marina ^a   Wang, Wei ^b   Williams, John P ^b,c,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Calmodulin kinase II; Glucose transport; Metabolism; Osteoclast

Indexed keywords

ADENOSINETRIPHOSPHATE; BIOASSAY; DATA ACQUISITION; ENZYME KINETICS; METABOLISM; PROTEINS;

CALMODULIN KINASE II; GLUCOSE TRANSPORT; OSTEOCLAST;

GLUCOSE;

ACETIC ACID DERIVATIVE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM CHELATING AGENT; CALCIUM ION; DEOXYGLUCOSE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID TETRAKIS(ACETOXYMETHYL) ESTER; GLUCOSE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; GLUCOSE TRANSPORT; METABOLIC REGULATION; NONHUMAN; OSTEOCLAST; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CHICKENS; FEMALE; GLUCOSE; OSTEOCLASTS;

ANIMALIA;

EID: 29144512729     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o05-136     Document Type: Article

References (49)

1. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ. Res. 81: 575-584.
2. 2+/calmodulin-dependent protein kinase II in pancreatic islets. Temporal dissociation of kinase activation and insulin secretion. Biochem. J. 317(Pt. 1): 167-172.
3. Bartkiewicz, M., Hernando, N., Reddy, S.V., Roodman, G.D., and Baron, R. 1995. Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit. Gene, 160: 157-164.
4. Blair, H.C., Teitelbaum, S.L., Ghiselli, R., and Gluck, S. 1989. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science (Wash. D.C.), 245: 855-857.
5. Blair, H.C., Teitelbaum, S.L., Tan, H.L., Koziol, C.M., and Schlesinger, P.H. 1991. Passive chloride permeability charge coupled to H(+)-ATPase of avian osteoclast ruffled membrane. Am. J. Physiol. 260: C1315-C1324.
6. Blair, H.C., Teitelbaum, S.L., Grosso, L.E., Lacey, D.L., Tan, H.L., McCourt, D.W., and Jeffrey, J.J. 1993. Extracellular-matrix degradation at acid pH. Avian osteoclast acid collagenase isolation and characterization. Biochem. J. 290(Pt. 3): 873-884.
7. Bouillon, R. 1990. Diabetic bone disease. Calcif. Tissue Int. 49: 155-160.
8. Chatterjee, D., Chakraborty, M., Leit, M., Neff, L., Jamsa-Kellokumpu, S., Fuchs, R. et al. 1992. The osteoclast proton pump differs in its pharmacology and catalytic subunits from other vacuolar H(+)-ATPases. J. Exp. Biol. 172: 193-204.
9. Chau, D.L., Edelman, S.V., and Chandran, M. 2003. Osteoporosis and diabetes. Curr. Diab. Rep. 3: 37-42.
10. Civelek, V.N., Deeney, J.T., Kubik, K., Schultz, V., Tornheim, K., and Corkey, B.E. 1996. Temporal sequence of metabolic and ionic events in glucose-stimulated clonal pancreatic beta-cells (HIT). Biochem. J. 315(Pt. 3): 1015-1019.
11. Cohen, P. 2002. The origins of protein phosphorylation. Nat. Cell Biol. 4: E127-E130.
12. 2+ and the ATP/ADP ratio in permeabilized RINm5F insulinoma cells supplemented with a glycolyzing cell-free muscle extract. J. Biol. Chem. 263: 4254-4258.
13. 2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem. J. 333(Pt. 2): 269-274.
14. Dienel, G.A., Cruz, N.F., and Sokoloff, L. 1993. Metabolites of 2-deoxy-[14C]glucose in plasma and brain: influence on rate of glucose utilization determined with deoxyglucose method in rat brain. J. Cereb. Blood Flow. Metab. 13: 315-327.
15. Dong, S.S., Williams, J.P., Jordan, S.E., Cornwell, T., and Blair, H.C. 1999. Nitric oxide regulation of cGMP production in osteoclasts. J. Cell Biochem. 73: 478-487.
16. 2+/calmodulin-dependent protein kinase II with the initiation of insulin secretion from perifused pancreatic islets. Endocrinology, 138: 2359-2364.
17. Fujikawa, Y., Quinn, J.M., Sabokbar, A., McGee, J.O., and Athanasou, N.A. 1996. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology, 137: 4058-4060.
18. 2+/calmodulin-dependent protein kinases. J. Biochem. (Tokyo), 129: 193-199.
19. Gould, G.W., Cuenda, A., Thomson, F.J., and Cohen, P. 1995. The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells. Biochem. J. 311: 735-738.
20. Haffner, S.M., and Bauer, R.L. 1993. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism, 42: 735-738.
21. Hedges, J.C., Yamboliev, I.A., Ngo, M., Horowitz, B., Adam, L.P., and Gerthoffer, W.T. 1998. p38 mitogen-activated protein kinase expression and activation in smooth muscle. Am. J. Physiol. 275: C527-C534.
22. Igarashi, M., Wakasaki, H., Takahara, N., Ishii, H., Jiang, Z.Y., Yamauchi, T. et al. 1999. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J. Clin. Invest. 103: 185-195.
23. Katoh, T., and Fujisawa, H. 1991. Calmodulin-dependent protein kinase II. Kinetic studies on the interaction with substrates and calmodulin. Biochim. Biophys. Acta, 1091: 205-212.
24. 2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J. Biol. Chem. 278: 8286-8293.
25. Krakauer, J.C., McKenna, M.J., Buderer, N.F., Rao, D.S., Whitehouse, F.W., and Parfitt, A.M. 1995. Bone loss and bone turnover in diabetes. Diabetes, 44: 775-782.
26. Krebs, E.G. 1993. Nobel Lecture. Protein phosphorylation and cellular regulation I. Biosci. Rep. 13: 127-142.
27. Larsen, K.I., Falany, M.L., Ponomareva, L.V., Wang, W., and Williams, J.P. 2002. Glucose-dependent regulation of osteoclast H(+)-ATPase expression: potential role of p38 MAP-kinase. J. Cell Biochem. 87: 75-84.
28. Lee, B.S., Gluck, S.L., and Holliday, L.S. 1999. Interaction between vacuolar H(+)-ATPase and microfilaments during osteoclast activation. J. Biol. Chem. 274: 29164-29171.
29. Leidig-Bruckner, G., and Ziegler, R. 2001. Diabetes mellitus a risk for osteoporosis? Exp. Clin. Endocrinol Diabetes. 109(Suppl. 2): S493-S514.
30. +-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. J. Biol. Chem. 276: 30407-30413.
31. Lu, H., Kraut, D., Gerstenfeld, L.C., and Graves, D.T. 2003. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology, 144: 346-352.
32. Macfarlane, W.M., Smith, S.B., James, R.F., Clifton, A.D., Doza, Y.N., Cohen, P., and Docherty, K. 1997. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells. J. Biol. Chem. 272: 20 936-20 944.
33. Matschinsky, F.M. 1990. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes, 39: 647-652.
34. Natarajan, R., Scott, S., Bai, W., Yemeni, K.K., and Nadler, J. 1999. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension, 33: 378-384.
35. 2+ in glucose-stimulated pancreatic beta-cells. Biochem. J. 314(Pt. 1): 91-94.
36. Puche, R.C. 1999. Expression of insulin receptors in osteoclast-like cells. Bone (N.Y.), 25: 251.
37. Quinn, J.M., Neale, S., Fujikawa, Y., McGee, J.O., and Athanasou, N.A. 1998. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif. Tissue Int. 62: 527-531.
38. Romero, D.F., Bryer, H.P., Rucinski, B., Isserow, J.A., Buchinsky, F.J., Cvetkovic, M. et al. 1995. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif. Tissue Int. 56: 54-61.
39. Schultz, V., Sussman, I., Bokvist, K., and Tornheim, K. 1993. Bioluminometric assay of ADP and ATP at high ATP/ADP ratios: assay of ADP after enzymatic removal of ATP. Anal. Biochem. 215: 302-304.
40. Schwartz, A. V. 2003. Diabetes mellitus: Does it affect bone? Calcif. Tissue Int. 73: 515-519.
41. Somwar, R., Perreault, M., Kapur, S., Taha, C., Sweeney, G., Ramlal, T. et al. 2000. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. Diabetes, 49: 1794-1800.
42. +-ATPase interacts with phosphofructokinase-1 in humans. J. Biol. Chem. 278: 20013-20018.
43. Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A., and Klip, A. 1999. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J. Biol. Chem. 274: 10071-10078.
44. Takizawa, M., Kameyama, K., Maruyama, M., and Ishida, H. 2003. Bone loss in type 2 diabetes mellitus - diabetic osteopenia. Nippon Rinsho. 61: 287-291. [In Japanese.]
45. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science (Wash. D.C.), 289: 1504-1508.
46. Thomas, D.M., Udagawa, N., Hards, D.K., Quinn, J.M.W., Moseley, J.M., Findlay, D.M., and Best, J.D. 1998. Insulin receptor expression in primary and cultured osteoclast-like cells. Bone (N.Y.), 23: 181-186.
47. Uldry, M., Ibberson, M., Hosokawa, M., and Thorens, B. 2002. GLUT2 is a high affinity glucosamine transporter. FEBS. Lett. 524: 199-203.
48. +-ATPase and bone resorption by tamoxifen and calmodulin antagonists: effects independent of steroid receptors. J. Biol. Chem. 271: 12488-12495.
49. Williams, J.P., Blair, H.C., McDonald, J.M., McKenna, M.A., Jordan, S.E., Williford, J., and Hardy, R.W. 1997. Regulation of osteoclastic bone resorption by glucose. Biochem. Biophys. Res. Commun. 235: 646-651.